Tortugas Neuroscience

Tortugas NeuroscienceTortugas Neuroscience
Tortugas Neuroscience

Tortugas Neuroscience

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

DR 102024Active2Framingham, USA
Rate

About

Tortugas Neuroscience is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurological and neuropsychiatric disorders. The company launched with significant funding to advance its pipeline through clinical trials.
Frequently asked

What does Tortugas Neuroscience do?

Tortugas Neuroscience is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurological and neuropsychiatric disorders. The company launched with significant funding to advance its pipeline through clinical trials.

What is Tortugas Neuroscience's revenue?

StartupHub estimates Tortugas Neuroscience's annual revenue at $328K (range $179K to $823K, 69% confidence), based on comparable companies in the sector.

What is Tortugas Neuroscience's valuation?

StartupHub estimates Tortugas Neuroscience's effective valuation at $665.8M (range $410.0M to $984.0M, 23% confidence), based on comparable companies in the sector.

How much funding has Tortugas Neuroscience raised?

Tortugas Neuroscience has raised a total of $164M in funding. The most recent round on record is Series A.

Where is Tortugas Neuroscience headquartered?

Tortugas Neuroscience is headquartered in Framingham, Massachusetts, USA.

When was Tortugas Neuroscience founded?

Tortugas Neuroscience was founded in 2024.

What industry does Tortugas Neuroscience operate in?

Tortugas Neuroscience operates in Biotechnology, Pharmaceuticals, Healthcare, Neuroscience, Biotech, MedTech.

How many employees does Tortugas Neuroscience have?

Tortugas Neuroscience has approximately 2 people on record.

HEADCOUNT
2
DOMAIN RATING
10
Comments

No comments yet. Be the first to share your take.